Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Smith

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
RSC Advances|May 11, 2022
Electrodeposition of tin nanowires from a dichloromethane based electrolyteAndrew W Lodge, Mahboba M Hasan, Philip N Bartlett, et al.
Targeted Oncology|February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid TumorsJames J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.
Reviews in Fish Biology and Fisheries|May 1, 2023
Initial impacts of the COVID-19 pandemic on Australian fisheries production, research organisations and assessment: shocks, responses and implications for decision support and resilienceEmily M Ogier, David C Smith, Sian Breen, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2015
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70Taofeek Kunle Owonikoko, Arif Hussain, Walter Michael Stadler, et al.
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 26, 2018
Multimodal imaging provides insight into targeted therapy response in metastatic prostate cancer to the boneBenjamin A Hoff, Jean-Christophe Brisset, Stefanie Galbán, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2009
Subseafloor sedimentary life in the South Pacific GyreSteven D'Hondt, Arthur J Spivack, Robert Pockalny, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Living with prostate cancer: patients' and spouses' psychosocial status and quality of lifeLaurel L Northouse, Darlene W Mood, James E Montie, et al.
RSC Advances|May 11, 2022
Electrodeposition of tin nanowires from a dichloromethane based electrolyteAndrew W Lodge, Mahboba M Hasan, Philip N Bartlett, et al.
Targeted Oncology|February 14, 2023
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid TumorsJames J Harding, Christiane Jungels, Jean-Pascal Machiels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancerMatthew D Galsky, Eric J Small, William K Oh, et al.
Reviews in Fish Biology and Fisheries|May 1, 2023
Initial impacts of the COVID-19 pandemic on Australian fisheries production, research organisations and assessment: shocks, responses and implications for decision support and resilienceEmily M Ogier, David C Smith, Sian Breen, et al.
Cancer Chemotherapy and Pharmacology|November 19, 2015
First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70Taofeek Kunle Owonikoko, Arif Hussain, Walter Michael Stadler, et al.
Investigational New Drugs|January 28, 2020
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinomaDavid C Smith, Matthias Kroiss, Electron Kebebew, et al.
American Journal of Nuclear Medicine and Molecular Imaging|July 26, 2018
Multimodal imaging provides insight into targeted therapy response in metastatic prostate cancer to the boneBenjamin A Hoff, Jean-Christophe Brisset, Stefanie Galbán, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 30, 2009
Subseafloor sedimentary life in the South Pacific GyreSteven D'Hondt, Arthur J Spivack, Robert Pockalny, et al.
Cancer Chemotherapy and Pharmacology|June 18, 2016
Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumorsDavid C Smith, John Powderly, James J Lee, et al.
Pageof 17